{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:13:14Z","timestamp":1793506394131,"version":"4.5.0"},"reference-count":74,"publisher":"BMJ","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gut"],"published-print":{"date-parts":[[2001,4,1]]},"abstract":"<jats:p>Measurements of luminal pH in the normal gastrointestinal tract have shown a progressive increase in pH from the duodenum to the terminal ileum, a decrease in the caecum, and then a slow rise along the colon to the rectum. Some data in patients with ulcerative colitis suggest a substantial reduction below normal values in the right colon, while limited results in Crohn's disease have been contradictory. Determinants of luminal pH in the colon include mucosal bicarbonate and lactate production, bacterial fermentation of carbohydrates and mucosal absorption of short chain fatty acids, and possibly intestinal transit. Alterations in these factors, as a result of mucosal disease and changes in diet, are likely to explain abnormal pH measurements in inflammatory bowel disease (IBD). It is conceivable that reduced intracolonic pH in active ulcerative colitis impairs bioavailability of 5-aminosalicylic acid from pH dependent release formulations (Asacol, Salofalk) and those requiring cleavage by bacterial azo reductase (sulphasalazine, olsalazine, balsalazide), but further pharmacokinetic studies are needed to confirm this possibility. Reports that balsalazide and olsalazine may be more efficacious in active and quiescent ulcerative colitis, respectively, than Asacol suggest that low pH may be a more critical factor in patients taking directly pH dependent release than azo bonded preparations. Reduced intracolonic pH also needs to be considered in the development of pH dependent colonic release formulations of budesonide and azathioprine for use in ulcerative and Crohn's colitis. This paper reviews methods for measuring gut pH, its changes in IBD, and how these may influence current and future therapies.<\/jats:p>","DOI":"10.1136\/gut.48.4.571","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T06:32:32Z","timestamp":1027751552000},"page":"571-577","source":"Crossref","is-referenced-by-count":654,"title":["Intestinal luminal pH in inflammatory bowel disease: possible determinants and implications for therapy with aminosalicylates and other drugs"],"prefix":"10.1136","volume":"48","author":[{"given":"S G","family":"NUGENT","sequence":"first","affiliation":[{"name":"Department of Surgery, St George's Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"KUMAR","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D S","family":"RAMPTON","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D F","family":"EVANS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2001,4,1]]},"reference":[{"key":"2025121307451116000_48.4.571.1","first-page":"183","article-title":"Intraluminal pH of the human gastrointestinal tract.","volume":"46","author":"Fallingborg","year":"1999","journal-title":"Dan Med Bull"},{"key":"2025121307451116000_48.4.571.2","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1136\/bmj.2.5805.104","article-title":"pH profile of gut as measured by radiotelemetry capsule.","volume":"2","author":"Watson","year":"1972","journal-title":"BMJ"},{"key":"2025121307451116000_48.4.571.3","doi-asserted-by":"publisher","DOI":"10.1136\/gut.15.12.999"},{"key":"2025121307451116000_48.4.571.4","doi-asserted-by":"publisher","DOI":"10.1136\/gut.29.8.1035"},{"key":"2025121307451116000_48.4.571.5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1989.tb00254.x"},{"key":"2025121307451116000_48.4.571.6","first-page":"A681","article-title":"Gastrointestinal pH profiles in ulcerative colitis.","volume":"102","author":"Raimundo","year":"1992","journal-title":"Gastroenterology"},{"key":"2025121307451116000_48.4.571.7","doi-asserted-by":"publisher","DOI":"10.1007\/BF01297074"},{"key":"2025121307451116000_48.4.571.8","doi-asserted-by":"publisher","DOI":"10.1023\/A:1018893409596"},{"key":"2025121307451116000_48.4.571.9","first-page":"114","article-title":"Improved localizing method of radiopill in measurement of entire gastrointestinal pH profiles: colonic luminal pH in normal subjects and patients with Crohn's disease.","volume":"92","author":"Sasaki","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"2025121307451116000_48.4.571.10","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1998.00358.x"},{"key":"2025121307451116000_48.4.571.11","doi-asserted-by":"publisher","DOI":"10.1023\/A:1026664105112"},{"key":"2025121307451116000_48.4.571.12","doi-asserted-by":"crossref","unstructured":"Nugent SG, Rampton DS, Kumar D, et al. Gut pH and transit time in ulcerative colitis appear sufficient for complete dissolution of pH-dependent 5-ASA containing capsules. Gut2000;47: (abstract).","DOI":"10.1016\/S1590-8658(00)80222-4"},{"key":"2025121307451116000_48.4.571.13","first-page":"213","article-title":"An accurate, long-term, pH-sensitive radio pill for ingestion and implantation.","volume":"8","author":"Colson","year":"1981","journal-title":"Biotelem Patient Monit"},{"key":"2025121307451116000_48.4.571.14","doi-asserted-by":"publisher","DOI":"10.1007\/BF01316512"},{"key":"2025121307451116000_48.4.571.15","doi-asserted-by":"publisher","DOI":"10.1136\/gut.28.6.707"},{"key":"2025121307451116000_48.4.571.16","first-page":"789","article-title":"Intestinal obstruction caused by a Heidelberg capsule: report of a case.","volume":"80","author":"Faegenburg","year":"1985","journal-title":"Am J Gastroenterol"},{"key":"2025121307451116000_48.4.571.17","doi-asserted-by":"publisher","DOI":"10.1016\/s0016-5085(88)80078-7"},{"key":"2025121307451116000_48.4.571.18","first-page":"549","article-title":"In vivo dialysis of faeces as a method of stool analysis. IV. The organic anion component.","volume":"37","author":"Rubinstein","year":"1969","journal-title":"Clin Sci"},{"key":"2025121307451116000_48.4.571.19","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(80)91934-0"},{"key":"2025121307451116000_48.4.571.20","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/32.10.2094"},{"key":"2025121307451116000_48.4.571.21","unstructured":"Wrong O Edmonds C Chadwick V (1981) The large intestine: Its role in mammalian nutrition and homeostasis. (MTP press, Lancaster, UK), pp 133\u2013155."},{"key":"2025121307451116000_48.4.571.22","first-page":"A1366","article-title":"Effect of dietary fibre on colonic pH in healthy volunteers.","volume":"28","author":"Pye","year":"1987","journal-title":"Gut"},{"key":"2025121307451116000_48.4.571.23","doi-asserted-by":"publisher","DOI":"10.1042\/cs0430101"},{"key":"2025121307451116000_48.4.571.24","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1042\/cs093002Pa","article-title":"Is cholelithiasis an intestinal disease? A study of five inter-related factors.","volume":"93","author":"Thomas","year":"1997","journal-title":"Clin Sci"},{"key":"2025121307451116000_48.4.571.25","doi-asserted-by":"publisher","DOI":"10.1159\/000050407"},{"key":"2025121307451116000_48.4.571.26","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.37.6.704"},{"key":"2025121307451116000_48.4.571.27","doi-asserted-by":"publisher","DOI":"10.1136\/gut.35.1.73"},{"key":"2025121307451116000_48.4.571.28","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.35.3.323"},{"key":"2025121307451116000_48.4.571.29","doi-asserted-by":"publisher","DOI":"10.1136\/gut.38.6.886"},{"key":"2025121307451116000_48.4.571.30","doi-asserted-by":"publisher","DOI":"10.1136\/gut.34.11.1552"},{"key":"2025121307451116000_48.4.571.31","doi-asserted-by":"publisher","DOI":"10.1007\/BF02065554"},{"key":"2025121307451116000_48.4.571.32","doi-asserted-by":"publisher","DOI":"10.1007\/BF02148853"},{"key":"2025121307451116000_48.4.571.33","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(87)90554-3"},{"key":"2025121307451116000_48.4.571.34","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/gut.6.4.325","article-title":"Upper intestinal motility in ulcerative colitis, idiopathic steatorrhoea, and the irritable colon.","volume":"6","author":"Ritchie","year":"1965","journal-title":"Gut"},{"key":"2025121307451116000_48.4.571.35","doi-asserted-by":"publisher","DOI":"10.1159\/000202102"},{"key":"2025121307451116000_48.4.571.36","doi-asserted-by":"publisher","DOI":"10.1136\/gut.11.8.688"},{"key":"2025121307451116000_48.4.571.37","doi-asserted-by":"publisher","DOI":"10.1136\/gut.3.4.301"},{"key":"2025121307451116000_48.4.571.38","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(91)90079-Z"},{"key":"2025121307451116000_48.4.571.39","first-page":"892","article-title":"An experiment to determine the active therapeutic moiety of sulphasalazine.","volume":"2","author":"AzadKhan","year":"1977","journal-title":"Lancet"},{"key":"2025121307451116000_48.4.571.40","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-2125.1983.tb04983.x","article-title":"Colonic release of 5-aminosalicylic acid slow release from an oral preparation in active ulcerative colitis.","volume":"16","author":"Dew","year":"1983","journal-title":"Br J Clin Pharmacol"},{"key":"2025121307451116000_48.4.571.41","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/S0016-5085(82)80075-9","article-title":"5-aminosalicylic acid in a slow release preparation: Bioavailability, plasma levels, and excretion in humans.","volume":"83","author":"Rasmussen","year":"1982","journal-title":"Gastroenterology"},{"key":"2025121307451116000_48.4.571.42","doi-asserted-by":"publisher","DOI":"10.1136\/gut.28.2.196"},{"key":"2025121307451116000_48.4.571.43","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1365-2036.1993.tb00110.x","article-title":"Review article: the mode of action of the aminosalicylates in inflammatory bowel disease.","volume":"7","author":"Greenfield","year":"1993","journal-title":"Aliment Pharmacol Ther"},{"key":"2025121307451116000_48.4.571.44","doi-asserted-by":"publisher","DOI":"10.1016\/0950-3528(94)90002-7"},{"key":"2025121307451116000_48.4.571.45","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/0016-5085(89)91412-1","article-title":"Colonic N-acetylation of 5-aminosalicylic acid in inflammatory bowel disease.","volume":"97","author":"Allgayer","year":"1989","journal-title":"Gastroenterology"},{"key":"2025121307451116000_48.4.571.46","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.3109\/00365528809101549","article-title":"Studies on the acetylating capacity of human colonic epithelial cells for 5-aminosalicylic acid.","volume":"148","author":"Ireland","year":"1988","journal-title":"Scand J Gastroenterol"},{"key":"2025121307451116000_48.4.571.47","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-2125.1988.tb03383.x","article-title":"Delayed-release mesalazine (5-aminosalicylic acid): coat dissolution and excretion in ileostomy subjects.","volume":"26","author":"Riley","year":"1988","journal-title":"Br J Clin Pharmacol"},{"key":"2025121307451116000_48.4.571.48","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1365-2036.1990.tb00499.x","article-title":"Topical and systemic availability of 5-aminosalicylate: comparisons of three controlled release preparations in man.","volume":"4","author":"Christensen","year":"1990","journal-title":"Aliment Pharmacol Ther"},{"key":"2025121307451116000_48.4.571.49","doi-asserted-by":"crossref","first-page":"863","DOI":"10.3109\/00365529209000155","article-title":"Disposition of mesalazine from mesalazine-delivering drugs in patients with inflammatory bowel disease, with and without diarrhoea.","volume":"27","author":"Rijk","year":"1992","journal-title":"Scand J Gastroenterol"},{"key":"2025121307451116000_48.4.571.50","first-page":"A242","article-title":"Release of 5-aminosalicyclic acid is reduced at pH below 5.4.","volume":"47 (suppl III)","author":"Nugent","year":"2000","journal-title":"Gut"},{"key":"2025121307451116000_48.4.571.51","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.3109\/00365528909090784","article-title":"Disposition of 5-aminosalicylic acid from 5-aminosalicylic acid delivering drugs during accelerated intestinal transit in healthy volunteers.","volume":"24","author":"Rijk","year":"1989","journal-title":"Scand J Gastroenterol"},{"key":"2025121307451116000_48.4.571.52","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2125.1987.tb03061.x","article-title":"Release of 5-aminosalicylic acid from Pentasa during normal and accelerated intestinal transit time.","volume":"23","author":"Christensen","year":"1987","journal-title":"Br J Clin Pharmacol"},{"key":"2025121307451116000_48.4.571.53","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1365-2036.1994.tb00290.x","article-title":"Comparative bioavailability of 5-aminosalicylic acid from a controlled release preparation and an azo-bond preparation.","volume":"8","author":"Christensen","year":"1994","journal-title":"Aliment Pharmacol Ther"},{"key":"2025121307451116000_48.4.571.54","doi-asserted-by":"publisher","DOI":"10.1136\/gut.31.11.1271"},{"key":"2025121307451116000_48.4.571.55","doi-asserted-by":"publisher","DOI":"10.1136\/gut.28.9.1084"},{"key":"2025121307451116000_48.4.571.56","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)70627-4"},{"key":"2025121307451116000_48.4.571.57","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1136\/bmj.2.5321.1708","article-title":"Comparison of corticosteroid and sulphasalazine therapy in ulcerative colitis.","volume":"2","author":"Truelove","year":"1962","journal-title":"BMJ"},{"key":"2025121307451116000_48.4.571.58","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)95624-2"},{"key":"2025121307451116000_48.4.571.59","first-page":"204","article-title":"Ulcerative colitis practice guidelines in adults.","volume":"297","author":"Kornbluth","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"2025121307451116000_48.4.571.60","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-118-7-199304010-00009"},{"key":"2025121307451116000_48.4.571.61","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)91601-4"},{"key":"2025121307451116000_48.4.571.62","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1998.00427.x"},{"key":"2025121307451116000_48.4.571.63","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(93)90337-C"},{"key":"2025121307451116000_48.4.571.64","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199808063390603"},{"key":"2025121307451116000_48.4.571.65","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-199412000-00003"},{"key":"2025121307451116000_48.4.571.66","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1997.v113.pm9352848"},{"key":"2025121307451116000_48.4.571.67","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00501.x"},{"key":"2025121307451116000_48.4.571.68","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199409293311304"},{"key":"2025121307451116000_48.4.571.69","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)70254-9"},{"key":"2025121307451116000_48.4.571.70","unstructured":"Entocort information pack. AstraZeneca2000."},{"key":"2025121307451116000_48.4.571.71","unstructured":"Mollmann H Barth J Hochhaus G (1996) Principles of topical versus systemic corticoid treatment in inflammatory bowel disease. Mollmann H, May B. Glucocorticoid therapy in chronic inflammatory bowel disease\u2014from basic principles to rational therapy. (Kluwer Academic, Dordrect), pp 42\u201360."},{"key":"2025121307451116000_48.4.571.72","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600840603"},{"key":"2025121307451116000_48.4.571.73","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-123-2-199507150-00009"},{"key":"2025121307451116000_48.4.571.74","doi-asserted-by":"publisher","DOI":"10.1177\/009127009703700107"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gut.48.4.571","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T15:45:22Z","timestamp":1765640722000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gut.48.4.571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,4,1]]},"references-count":74,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2001,4,1]]},"published-print":{"date-parts":[[2001,4,1]]}},"alternative-id":["10.1136\/gut.48.4.571"],"URL":"https:\/\/doi.org\/10.1136\/gut.48.4.571","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,4,1]]}}}